How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, Anthropic boasted that Claude is now writing 80% of Anthropic’s code, which the company presented as a harbinger of a critical leap in artificial intelligence called recursive ...

Recursive self-improvement AI now has a co-evolving evaluator: a Cambridge and NVIDIA preprint introduces the Red Queen Gödel ...

Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $3.06, moving -5.12% from the previous trading session. This change lagged the S&P 500's daily loss of 1.62%. Meanwhile, the Dow ...

Get the undefined latest Balance Sheet, Financial Statements, and the undefined detailed insights on assets, liabilities, and equity. Get more insights into the bank's financial position, growth, and ...

De Freitas, Julian, Y. Huang, and Steven Pinker. "Recursive Mentalizing and Public Salience in the Perception of Common Knowledge." Proceedings of the National Academy of Sciences (in press).